Your browser doesn't support javascript.
loading
Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production.
Nakamura, Masaki; Zhang, Yin; Yang, Yunlong; Sonmez, Ceylan; Zheng, Wenyi; Huang, Guichun; Seki, Takahiro; Iwamoto, Hideki; Ding, Bo; Yin, Linlin; Foukakis, Theodoros; Hatschek, Thomas; Li, Xuri; Hosaka, Kayoko; Li, Jiaping; Yu, Guohua; Wang, Xinsheng; Liu, Yizhi; Cao, Yihai.
Afiliação
  • Nakamura M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Zhang Y; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Yang Y; Central Research Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China.
  • Sonmez C; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Zheng W; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Huang G; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Seki T; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Iwamoto H; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Ding B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Yin L; Department of Hematology and Oncology, The Fourth Hospital of Jinan, Jinan, Shandong 250031, China.
  • Foukakis T; Department of Hematology and Oncology, The Fourth Hospital of Jinan, Jinan, Shandong 250031, China.
  • Hatschek T; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, 171 77 Stockholm, Sweden.
  • Li X; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, 171 77 Stockholm, Sweden.
  • Hosaka K; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, China.
  • Li J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Yu G; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, P. R. China; jpli3s@126.com baohongy@me.com qdfywxs@163.com yizhi_liu@aliyun.com yihai.cao@ki.se.
  • Wang X; Wei Fang People's Hospital, Kui Wen District, Weifang, Shandong, China jpli3s@126.com baohongy@me.com qdfywxs@163.com yizhi_liu@aliyun.com yihai.cao@ki.se.
  • Liu Y; Central Research Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China; jpli3s@126.com baohongy@me.com qdfywxs@163.com yizhi_liu@aliyun.com yihai.cao@ki.se.
  • Cao Y; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, China; jpli3s@126.com baohongy@me.com qdfywxs@163.com yizhi_liu@aliyun.com yihai.cao@ki.se.
Proc Natl Acad Sci U S A ; 114(45): E9635-E9644, 2017 11 07.
Article em En | MEDLINE | ID: mdl-29078273

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Eritropoetina / Inibidores da Angiogênese / Rim / Neovascularização Patológica / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Eritropoetina / Inibidores da Angiogênese / Rim / Neovascularização Patológica / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia